← Best peptides for Weight Loss & Metabolic HealthSee the PubMed search behind the study count ↗
Weight Loss & Metabolic Health · #2 most researched
Tirzepatide
Also known as: Mounjaro, Zepbound, LY3298176
Dual GIP/GLP-1 receptor agonist; head-to-head trials show larger average weight loss than GLP-1-only agents.
Research use only. Nothing here is medical advice; this compound is not approved for human consumption outside prescription use.
Tirzepatide at a glance
MechanismGLP-1/GIP dual agonist
Evidence tierHuman trials
Regulatory statusApproved (prescription)
Indexed studies1,848
Approx. half-lifeAbout 5 days
Studied routeSubcutaneous injection
Vial sizes on file10–60 mg
Tracked vendors3 (2 verified)
Where to buy Tirzepatide
Verified vendors first, then lowest priceResearch areas
Dual GIP/GLP-1 signallingGlycaemic controlBody weight
Commonly researched alongside
VialCheck record
We track 3 vendors listing Tirzepatide. 2 of them (67%) have verified batches on file with VialCheck. Lowest price is not the same as lowest risk — check the batch COA before you order.


